FDA 483 - Darrell T. Herrington, DO - December 16, 2022

Darrell T. Herrington, DO in San Angelo, TX was inspected from December 5-16, 2022, revealing significant deficiencies in clinical trial documentation. The inspection found failures to maintain adequate and accurate case histories and source documentation, impacting data integrity and patient safety. Issues included missing records, incomplete consent processes, unreported adverse events, and incorrect drug accountability.